Regulation of receptor trafficking by GRKs and arrestins

Annual Review of Physiology

Volumn 69, Issue , 2007, Pages 451-482

  Moore, Catherine A C ^a   Milano, Shawn K ^a   Benovic, Jeffrey L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Endocytosis; GPCR; Internalization; Sorting

Indexed keywords

ADAPTOR PROTEIN; CLATHRIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; RETINA S ANTIGEN;

CELL MEMBRANE; ENDOCYTOSIS; HUMAN; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; PROTEIN TRANSPORT; RECYCLING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; ENDOCYTOSIS; HUMANS; MODELS, MOLECULAR; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSPORT VESICLES;

EID: 33947314576     PISSN: 00664278     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.physiol.69.022405.154712     Document Type: Review

References (212)

1. Schmid SL. 1997. Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu. Rev. Biochem. 66:511-48
2. Kirchhausen T. 2000. Clathrin. Annu. Rev. Biochem. 69:699-727
3. Chini B, Parenti M. 2004. G-protein coupled receptors in lipid rafts and caveolae: How, when, and why do they go there? J. Molec. Endocrin. 32:325-38
4. Anderson RGW. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67:199-225
5. Nichols BJ, Lippencott-Schwartz J. 2001. Endocytosis without clathrin coats. Trends Cell Biol. 11:406-12
6. Krupnick JG, Benovic JL. 1998. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38:289-319
7. Marchese A, Chen CA, Kim YM, Benovic JL. 2003. The ins and outs of G protein-coupled receptor trafficking. Trends Biochem. Sci. 28:369-76
8. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. 2000. Differential affinities of visual arrestin, βarrestin1, and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:17201-10
9. Zhang J, Barak LS, Anborgh PH, Laporte SA, Caron MG, Ferguson SSG. 1999. Cellular trafficking of G protein-coupled receptor/β-arrestin endocytic complexes. J. Biol. Chem. 274:10999-11006
10. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 2001. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis. J. Biol. Chem. 276:19452-60
11. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG. 1999. Association of β-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J. Biol. Chem. 274:32248-57
12. Innamorati G, Le Gouill C, Balamotis M, Birnbaumer M. 2001. The long and the short cycle. Alternative intracellular routes for trafficking of G protein-coupled receptors. J. Biol. Chem. 276:13096-103
13. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, et al. 2006. β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J. Biol. Chem. 281:1261-73
14. Shenoy SK, Lefkowitz RJ. 2005. Receptor-specific ubiquitination of β-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J. Biol. Chem. 280:15315-24
15. Shenoy SK, Lefkowitz RJ. 2003. Trafficking patterns of β-arrestin and G protein-coupled receptors determined by the kinetics of β-arrestin deubiquitination. J. Biol. Chem. 278:14498-506
16. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72:395-447
17. Scott MG, Benmerah A, Mutaner O, Marullo S. 2002. Recruitment of activated G protein-coupled receptors to pre-existing clathrin-coated pits in living cells. J. Biol. Chem. 277:3552-59
18. Santini F, Gaidarov I, Keen JH. 2002. G protein-coupled receptor/arrestin3 modulation of the endocytic machinery. J. Cell Biol. 156:665-76
19. Blanpied TA, Scott DB, Ehlers MD. 2002. Dynamics and regulation of clathrin coats at specialized endocytic zones of dendrites and spines. Neuron 36:435-49
20. Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I, et al. 1995. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269:1872-75
21. Honig S, Ricotta D, Krauss M, Spate K, Spolaore B, et al. 2005. Phosphatidylinositol-(4,5)-bisphosphate regulates sorting signal recognition by the clathrin-associated adapter complex AP2. Mol. Cell 18:519-31
22. Paing MM, Temple BRS, Trejo J. 2004. A tyrosine-based sorting signal regulates intracellular trafficking of protease-activa ted receptor-1. J. Biol. Chem. 279:21938-47
23. Paing MM, Johnston CA, Siderovski DP, Trejo J. 2006. Clathrin adapter AP2 regulates thrombin receptor constitutive internalization and endothelial cell resensitization. Mol. Cell. Biol. 26:3231-42
24. 2 receptor trafficking. Identification of a distinct motif for tonic internalization. J. Biol. Chem. 276:7079-85
25. Diviani D, Lattion AL, Abuin L, Staub O, Cotecchia S. 2003. The adapter complex 2 directly interacts with the β1b-adrenergic receptor and plays a role in receptor endocytosis. J. Biol. Chem. 278:19331-40
26. Fan GH, Yang W, Wang XJ, Qian Q, Richmond A. 2001. Identification of a motif in the carboxyl terminus of CXCR2 that is involved in adaptin 2 binding and receptor internalization. Biochemistry 40:791-800
27. Orsini MJ, Parent JL, Mundell SJ, Marchese A, Benovic JL. 2000. Trafficking of the HIV coreceptor CXCR4: role of arrestins and identification of residues in the C-terminal tail that mediate receptor internalization. J. Biol. Chem. 274:31076-86
28. 2-adrenergic receptor is involved in receptor internalization. Proc. Natl. Acad. Sci. USA 94:12285-90
29. Robert J, Clauser E, Patit PX, Ventura MA. 2005. A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane. J. Biol. Chem. 280:2300-8
30. Duvernay MT, Zhou F, Wu G. 2004. A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 279:30741-50
31. Zhao M, Wimmer A, Trieu K, DiScipio RG, Schraufstatter IU. 2004. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J. Biol. Chem. 279:49259-67
32. Kohout TA, Lin FT, Perry SJ, Conner DA, Lefkowitz RJ. 2001. β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc. Natl. Acad. Sci. USA 98:1601-6
33. Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A. 2005. Altered CXCR2 signaling in β-arrestin-2-deficient mouse models. J. Immunol. 175:5396-402
34. Ahn S, Nelson CD, Garrison TR, Miller WE, Lefkowitz RJ. 2003. Desensitization, internalization, and signaling function of β-arrestins demonstrated by RNA interference. Proc. Natl. Acad. Sci. USA 100:1740-44
35. Cheng ZJ, Zhao J, Sun Y, Hu W, Wu YL, et al. 2000. β-Arrestin differentially regulates the chemokine receptor CXCR4-mediated signaling and receptor internalization, and this implicates multiple interaction sites between β-arrestin and CXCR4. J. Biol. Chem. 275:2479-85
36. Fong AM, Premont RT, Richardson RM, Yu YRA, Lefkowitz RJ, Patel DD. 2002. Defective lymphocyte chemotaxis in β-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. USA 99:7478-83
37. Sun Y, Cheng Z, Pei G. 2002. β-Arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277:49212-19
38. Ge L, Chenoy SK, Lefkowitz RJ, DeFea K. 2004. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both β-arrestin-1 and -2. J. Biol. Chem. 279:55419-24
39. Parent JL, Labrecque P, Orsini MJ, Benovic JL. 1999. Internalization of the TXA2 receptor α and β isoforms. J. Biol. Chem. 274:8941-48
40. Dale LB, Bhattacharya M, Seachrist JL, Anborgh PIT, Ferguson SSG. 2001. Agonist-stimulated and tonic internalization of metabotropic glutamate receptor 1a in human embryonic kidney 293 cells: Agonist-stimulated endocytosis is β-arrestin1 isoform-specific. Mol. Pharmacol. 60:1243-53
41. Shapiro MJ, Coughlin SR. 1998. Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor-1. J. Biol. Chem. 273:29009-14
42. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. 2002. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol. Metab. 13:336-43
43. Barak LS, Oakley RH, Laporte SA, Caron MG. 2001. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. Proc. Natl. Acad. Sci. USA 98:93-98
44. Whistler JL, Gerber BO, Meng EC, Baranski TJ, Von Zastrow M, Bourne HR. 2002. Constitutive activation and endocytosis of the complement factor 5a receptor: Evidence for multiple activated conformations of a G protein-coupled receptor. Traffic 3:866-77
45. Wilbanks AM, Laporte SA, Bohn LM, Barak LS, Caron MG. 2002. Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors. Biochemistry 41:11981-89
46. Fraile-Ramos A, Kledal TN, Pelchen-Matthews A, Bowers K, Schwartz TW, Marsh M. 2001. The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Mol. Biol. Cell 12:1737-49
47. Leterrier C, Laine J, Darmon M, Boudin H, Rossier J, Lenkei Z. 2006. Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. J. Neurosci. 26:3141-53
48. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, Traub LM. 2002. Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J. 21:4915-26
49. Fan GH, Yang W, Sai J, Richmond A. 2002. Hsc/Hsp70 interacting protein (hip) associates with CXCR2 and regulates the receptor signaling and trafficking. J. Biol. Chem. 277:6590-97
50. He G, Gupta S, Yi M, Michaely P, Hobbs HH, Cohen JC. 2002. ARH is a modular adaptor protein that interacts with the LDL receptor, clathrin, and AP-2. J. Biol. Chem. 277:44044-49
51. Santolini E, Puri C, Salcini AE, Gagliani MC, Pelicci PG, et al. 2000. Numb is an endocytic protein. J. Cell Biol. 151:1345-51
52. Reiter E, Lefkowitz RJ. 2006. GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol. Metab. 17:159-65
53. Deleted in proof
54. Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, et al. 2002. Differential nucleocytoplasmic shuttling of β-arrestins. Characterization of a leucine-rich nuclear export signal in β-arrestin2. J. Biol. Chem. 277:37693-701
55. Wang P, Wu Y, Ge X, Ma L, Pei G. 2003. Subcellular localization of β-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J. Biol. Chem. 278:11648-53
56. Kang J, Shi Y, Xiang B, Qu B, Su W, et al. 2005. A nuclear function of β-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123:833-47
57. Santini F, Penn RB, Gagnon AW, Benovic JL, Keen JH. 2000. Selective recruitment of arrestin-3 to clathrin coated pits upon stimulation of G protein-coupled receptors. J. Cell Sci. 113:2463-70
58. Gurevich VV, Gurevich EV. 2006. The structural basis of arrestin-mediated regulation of G-protein-eoupled receptors. Pharmacol. Ther. 110:465-502
59. Pitcher JA, Freedman NJ, Lefkowitz RJ. 1998. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67:653-92
60. Tsuga H, Kameyama K, Llaga T, Kurose H, Nagao T. 1994. Sequestration of muscarinic acetylcholine receptor m2 subtypes. Facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2. J. Biol. Chem. 269:32522-27
61. Ferguson SS. 2001. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 53:1-24
62. Shiina T, Arai K, Tanabe S, Yoshida N, Haga T, et al. 2001. Clathrin box in G protein-coupled receptor kinase 2. J. Biol. Chem. 276:33019-26
63. Naga Prasad SV, Barak LS, Rapacciuolo A, Caron MG, Rockman HA. 2001. Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by β-adrenergic receptor kinase 1. A role in receptor sequestration. J. Biol. Chem. 276:18953-59
64. Naga Prasad SV, Laporte SA, Chamberlain D, Caron MG, Barak L, Rockman HA. 2002. Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex. J. Cell Biol. 158:563-75
65. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA. 2005. Protein kinase activity of phosphoinositide 3-kinase regulates β-adrenergic receptor endocytosis. Nat. Cell Biol. 7:785-96
66. Perrino C, Naga Prasad SV, Schroder JN, Hata JA, Milano C, Rockman HA. 2005. Restoration of β-adrenergic receptor signaling and contractile function in heart failure by disruption of the βARK1/phosphoinositide 3-kinase complex. Circulation 111:2579-87
67. Cant SH, Pitcher JA. 2005. G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol. Biol. Cell 16:3088-99
68. Ferguson SS, Downey WE, Colapietro AM, Barak LS, Menard L, Caron MG. 1996. Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-66
69. Goodman OBJ., Krupnick JG, Santini F, Gurevich VV, Penn RB, et al. 1996. β-arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature 383:447-50
70. Granzin J, Wilden U, Choe HW, Labahn J, Krafft B, Buldt G. 1998. X-ray crystal structure of arrestin from bovine rod outer segments. Nature 391:918-21
71. Hirsch JA, Schubert C, Gurevich VV, Sigler PB. 1999. The 2.8 Å crystal structure of visual arrestin: a model for arrestin's regulation. Cell 97:257-69
72. Han M, Gurevich VV, Vishnivetskiy SA, Sigler PB, Schubert C. 2001. Crystal structure of β-arrestin at 1.9 Å. Possible mechanism of receptor binding and membrane translocation. Structure 9:869-80
73. Milano SK, Pace HC, Kim YM, Brenner C, Benovic JL. 2002. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis. Biochemistry 41:3321-28
74. Sutton RB, Vishnivetskiy SA, Robert J, Hanson SM, Raman D, et al. 2005. Crystal structure of cone arrestin at 2.3Å: evolution of receptor specificity. J. Mol. Biol. 354:1069-80
75. Vishnivetskiy SA, Hirsch JA, Velez MG, Gurevich YV, Gurevich VV. 2002. Arrestin's transition into the active receptor-binding state requires an extended interdomain hinge. J. Biol. Chem. 277:43961-67
76. Gurevich VV, Benovic JL. 1995. Visual arrestin binding to rhodopsin: diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin. J. Biol. Chem. 270:6010-16
77. Gurevich VV, Benovic JL. 1997. Mechanism of phosphorylation-recognition by visual arrestin and the transition of arrestin into a high affinity binding state. Mol. Pharmacol. 51:161-69
78. Kovoor A, Celver J, Abdryashitov RI, Chavkin C, Gurevich VV. 1999. Targeted construction of phosphorylation-independent β-arrestin mutants with constitutive activity in cells. J. Biol. Chem. 274:6831-34
79. Vishnivetskiy SA, Paz CL, Schubert C, Hirsch JA, Sigler PB, Gurevich VV. 1999. How does arrestin respond to the phosphorylated state of rhodopsin? J. Biol. Chem. 274:11451-54
80. Shilton BH, McDowell JH, Smith WC, Hargrave PA. 2002. The solution structure and activation of visual arrestin studied by small-angle X-ray scattering. Eur. J. Biochem. 269:3801-9
81. Carter JM, Gurevich VV, Prossnitz ER, Engen JR. 2005. Conformational differences between arrestin2 and preactivated mutants as revealed by hydrogen exchange mass spectrometry. J. Mol. Biol. 351:865-78
82. Charest PG, Terrillon S, Bouvier M. 2005. Monitoring agonist-promoted conformational changes of β-arrestin in living cells by intramolecular BRET. EMBO Rep. 6:334-40
83. Gurevich VV, Benovic JL. 1992. Cell-free expression of visual arrestin. Truncation mutagenesis identifies multiple domains involved in rhodopsin interaction. J. Biol. Chem. 267:21919-23
84. Gurevich VV, Benovic JL. 1993. Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J. Biol. Chem. 268:11628-38
85. Gurevich VV, Richardson RM, Kim CM, Hosey MM, Benovic JL. 1993. Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptor. J. Biol. Chem. 268:16879-82
86. Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, et al. 1995. Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, β2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol. Chem. 270:720-31
87. Vishnivetskiy SA, Hosey MM, Benovic JL, Gurevich VV. 2004. Mapping the arrestin-receptor interface. Structural elements responsible for receptor specificity of arrestin proteins. J. Biol. Chem. 279:1262-68
88. Hanson SM, Gurevich VV. 2006. The differential engagement of arrestin surface charges by the various functional forms of the receptor. J. Biol. Chem. 281:3458-62
89. Vishnivetskiy SA, Schubert C, Climaco GC, Gurevich YV, Velez MG, Gurevich VV. 2000. An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation. J. Biol. Chem. 275:41049-57
90. Krupnick JG, Goodman OBJ., Keen JH, Benovic JL. 1997. Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus. J. Biol. Chem. 272:15011-16
91. Shih W, Gallusser A, Kirchhausen T. 1995. A clathrin-binding site in the hinge of the β2 chain of mammalian AP-2 complexes. J. Biol. Chem. 270:31083-90
92. Morris SA, Schroder S. Plessmann U, Weber K, Ungewickell E. 1993. Clathrin assembly protein AP180: primary structure, domain organization and identification of a clathrin binding site. EMBO J. 12:667-75
93. Ramjaun AR, McPherson PS. 1998. Multiple amphiphysin II splice variants display differential clathrin binding: identification of two distinct clathrin-binding sites. J. Neurochem. 70:2369-76
94. Drake MT, Downs MA, Traub LM. 2000. Epsin binds to clathrin by associating directly with the clathrin-terminal domain. Evidence for cooperative binding through two discrete sites. J. Biol. Chem. 275:6479-89
95. Kim YM, Benovic JL. 2002. Differential roles of arrestin-2 interaction with clathrin and adaptor protein 2 in G protein-coupled receptor trafficking. J. Biol. Chem. 277:30760-68
96. Goodman OBJ, Krupnick JG, Gurevich VV, Benovic JL, Keen JH. 1997. Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain. J. Biol. Chem. 272:15017-22
97. ter Haar E, Harrison SC, Kirchhausen T. 2000. Peptide-in-groove interactions link target proteins to the β-propeller of clathrin. Proc. Natl. Acad. Sci. USA 97:1096-100
98. Laporte SA, Oakley RH, Zhang J, Holt JA, Ferguson SS, et al. 1999. The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc. Natl. Acad. Sci. USA 96:3712-17
99. Robinson MS, Bonifacino JS. 2001. Adaptor-related proteins. Curr. Opin. Cell Biol. 13:444-53
100. Laporte SA, Oakley RH, Holt JA, Barak LS, Caron MG. 2000. The interaction of β-arrestin with the AP-2 adaptor is required for the clustering of β2-adrenergic receptor into clathrin-coated pits. J. Biol. Chem. 275:23120-26
101. Edeling MA, Mishra SK, Keyel PA, Steinhauser AL, Collins BM, et al. 2006. Molecular switches involving the AP-2 β2 appendage regulate endocytic cargo selection and clathrin coat assembly. Dev. Cell 10:329-42
102. Laporte SA, Miller WE, Kim KM, Caron MG. 2002. β-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a β-arrestin binding site in β2-adaptin. J. Biol. Chem. 277:9247-54
103. Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, et al. 1997. Clathrin-mediated endocytosis of the β-adrenergic receptor is regulated by phosphorylation/dephosphorylation of β-arrestin1. J. Biol. Chem. 272:31051-57
104. Lin FT, Miller WE, Luttrell LM, Lefkowitz RJ. 1999. Feedback regulation of β-arrestin1 function by extracellular signal-regulated kinases. J. Biol. Chem. 274:15971-74
105. 2-adrenergic receptors. Biochemistry 41:10692-99
106. Kim YM, Barak LS, Caron MG, Benovic JL. 2002. Regulation of arrestin-3 phosphorylation by casein kinase II. J. Biol. Chem. 277:16837-46
107. Xiao K, Shenoy SK, Nobles K, Lefkowitz RJ. 2004. Activation-dependent conformational changes in β-arrestin 2. J. Biol. Chem. 279:55744-53
108. Gaidarov I, Krupnick JG, Falck JR, Benovic JL, Keen JH. 1999. Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO J. 18:871-81
109. Milano SK, Kim YM, Stefano FP, Benovic JL, Brenner C. 2006. Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J. Biol. Chem. 281:9812-23
110. Lee SJ, Xu H, Kang LW, Amzel LM, Montel C. 2003. Light adaptation through phosphoinositide-regulated translocation of Drosophila visual arrestin. Neuron 39:121-32
111. Sasakawa N, Sharif M, Hanley MR. 1995. Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem. Pharmacol. 50:137-46
112. Storez H, Scott MG, Issafras H, Burtey A, Benmerah A, et al. 2005. Homo- and heterooligomerization of β-arrestins in living cells. J. Biol. Chem. 280:40210-15
113. D'Souza-Schorey C, Chavrier P. 2006. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7:347-58
114. Donaldson JG. 2003. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J. Biol. Chem. 278:41573-76
115. Macia E, Chabre M, Franco M. 2001. Specificities for the small G proteins ARF1 and ARF6 of the guanine nucleotide exchange factors ARNO and EFA6. J. Biol. Chem. 276:24925-30
116. Frank S, Upender S, Hansen SH, Casanova JE. 1998. ARNO is a guanine nucleotide exchange factor for ADP-ribosylation factor 6. J. Biol. Chem. 273:23-27
117. Vitale N, Patton WA, Moss J, Vaughan M, Lefkowitz RJ, Premont RT. 2000. GIT proteins, a novel family of phosphatidylinositol 3,4,5-trisphosphate- stimulated GTPase-activating proteins for ARF6. J. Biol. Chem. 275:13901-6
118. Salvador LM, Mukherjee S, Kahn RA, Lamm MLG, Fazleabas AT, et al. 2001. Activation of the luteinizing hormone/choriogonadotropin hormone receptor promotes ADP ribosylation factor 6 activation in porcine ovarian follicular membranes. J. Biol. Chem. 276:33773-81
119. Mukherjee S, Casanova JE, Hunzicker-Dunn M. 2001. Desensitization of the luteinizing hormone/choriogonadotropin hormone receptor in ovarian follicular membranes is inhibited by catalytically inactive ARNO. J. Biol. Chem. 276:6524-28
120. Mukerjee S, Gurevich VV, Jones JCR, Casanova JE, Frank SR, et al. 2000. The ADP ribosylation factor nucleotide exchange factor ARNO promotes β-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization. Proc. Natl. Acad. Sci. USA 97:5901-6
121. Mukherjee S, Palczewski K, Gurevich VV, Hunzicker-Dunn M. 1999. β-Arrestin-dependent desensitization of luteinizing hormone/ choriogonadotropin receptor is prevented by a synthetic peptide corresponding to the third intracellular loop of the receptor. J. Biol. Chem. 274:12984-89
122. Mukherjee S, Palczewski K, Gurevich V, Benovic JL, Banga JP, Hunzicker-Dunn M. 1999. A direct role for arrestins in desensitization of the luteinizing hormone/choriogonadotropin receptor in porcine ovarian follicular membranes. Proc. Natl. Acad. Sci. USA 96:493-98
123. Mukherjee S, Gurevich VV, Preninger A, Hamm HE, Bader MF, et al. 2002. Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2. J. Biol. Chem. 277:17916-27
124. Premont RT, Claing A, Vitale N, Freeman JLR, Pitcher JA, et al. 1998. β2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc. Natl. Acad. Sci. USA 95:14082-87
125. Claing A, Perry SJ, Achiriloaie M, Walker JKL, Albanesi JP, et al. 2000. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. Proc. Natl. Acad. Sci. USA 97:1119-24
126. Claing A, Chen W, Miller WE, Vitale N, Moss J, et al. 2001. β-Arrestin-mediated ADP-ribosylation factor 6 activation and β2-adrenergic receptor endocytosis. J. Biol. Chem. 276:42509-13
127. Premont RT, Claing A, Vitale N, Perry SJ, Lefkowitz RJ. 2000. The GIT family of ADP-ribosylation factor GTPase-activating proteins: functional diversity of GIT2 through alternative splicing. J. Biol. Chem. 275:22373-80
128. Houndolo T, Boulay PL, Claing A. 2005. G protein-coupled receptor endocytosis in ADP-ribosylation factor 6-depleted cells. J. Biol. Chem. 280:5598-604
129. Delaney KA, Murph MM, Brown LM, Radhakrishna H. 2002. Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J. Biol. Chem. 277:33439-46
130. Naslavsky N, Weigert R, Donaldson JG. 2003. Convergence of nonclathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol. Biol. Cell 14:417-31
131. GTP recruits the AP-2 adaptor complex to membranes. J. Biol. Chem. 280:21661-66
132. Krauss M, Kinuta M, Wenk MR, De Camilli P, Takei K, Haucke V. 2003. ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Iγ. J. Cell Biol. 162:113-24
133. Mace G, Miaczynska M, Zerial M, Nebreda AR. 2005. Phosphorylation of EEA1 by p38 MAP kinase regulates μ opioid receptor endocytosis. EMBO J. 24:3235-46
134. McLaughlin NJD, Banerjee A, Kelher MR, Gamboni-Robertson F, Hamiel C, et al. 2006. Platelet-activating factor-induced clathrin-mediated endocytosis requires β-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. J. Immunol. 176:7039-50
135. q- dependent activation of phosphatidylinositol 3-kinase. Biochemistry 45:9374-85
136. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. 2007. β-Arrestins and cell signaling. Annu. Rev. Physiol. 69:483-510
137. DeFea KA, Zalevsky T, Thoma MS, Dery O, Mullins RD, Bunnett NW. 2000. β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J. Biol. Chem. 148:1267-81
138. Ge L, Ly Y, Hollenberg M, DeFea K. 2003. A β-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J. Biol. Chem. 278:34418-26
139. Stalheim L, Ding Y, Gullapalli A, Paing MM, Wolfe BL, et al. 2005. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking. Mol. Pharmacol. 67:78-87
140. Jacob C, Yang PC, Darmoul D, Amadesi S, Saito T, et al. 2005. Mast cell tryptase controls paracellular permeability. Role of PAR2 and β-arrestins. J. Biol. Chem. 280:31936-48
141. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field MF, et al. 2001. Activation and targeting of extracellular signal-regulated kinase by β-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98:2449-54
142. 1a receptor stimulation. J. Biol. Chem. 277:9429-36
143. Ahn S, Shenoy SK, Wei H, Lefkowitz RJ. 2004. Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 279:35518-25
144. Wei H, Ahn S, Barnes WG, Lefkowitz RJ. 2004. Stable interaction between β-arrestin 2 and angiotensin type 1A receptor is required for β-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 279:48255-61
145. Shenoy SK, Lefkowitz RJ. 2005. Receptor-specific ubiquitination of β-arrestin directs assembly and targeting of seven-transmembrane receptor signalosomes. J. Biol. Chem. 280:15315-24
146. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, et al. 2003. The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequences of ERK activation. J. Biol. Chem. 278:6258-67
147. Gage RM, Kim KA, Cao TT, von Zastrow M. 2001. A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors. J. Biol. Chem. 276:44712-20
148. Gage RM, Matveeva EA, Whiteheart SW, von Zastrow M. 2005. Type I PDZ ligands are sufficient to promote rapid recycling of G protein-coupled receptors independent of binding to NSF. J. Biol. Chem. 280:3305-13
149. A endothelin receptor by a novel endocytic recycling signal for G protein-coupled receptors. Mol. Pharmacol. 67:1581-90
150. Trejo J. 2005. Internal PDZ ligands: novel endocytic recycling motifs for G protein-coupled receptors. Mol. Pharmacol. 67:1388-90
151. Cong M, Perry SJ, Hu LA, Hanson PI, Claing A, Lefkowitz RJ. 2001. Binding of the β2 adrenergic receptor to N-ethylmaleimide-sensitive factor regulates receptor recycling. J. Biol. Chem. 276:45145-52
152. Cao TT, Deacon HW, Reczek D, Bretscher A, von Zastrow M. 1999. A kinase-regulated PDZ-domain interaction controls endocytic sorting of the β2-adrenergic receptor. Nature 401:286-90
153. Xiang Y, Kobilka N. 2003. The PDZ-binding motif of the β2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc. Natl. Acad. Sci. USA 100:10776-81
154. q signaling. Regulation by EBP50. J. Biol. Chem. 278:17827-37
155. McDonald PH, Cote NL, Lin FT, Premont RT, Pitcher JA, Lefkowitz RJ. 1999. Identification of NSF as a β-arrestin1-binding protein. J. Biol. Chem. 274:10677-80
156. Heydorn A, Sondergaard BP, Ersboll B, Holst B, Nielsen FC, et al. 2004 A library of 7TM receptor C-terminal tails. J. Biol. Chem. 279:54291-303
157. Weinman EJ, Hall RA, Friedman PA, Liu-Chen LY, Shenolikar S. 2006. The association of NHERF adaptor proteins with G protein-coupled receptors and receptor tyrosine kinases. Annu. Rev. Physiol. 68:491-505
158. Sneddon WB, Syme CA, Bisello A, Magyar CE, Rochdi MD, et al. 2003. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J. Biol. Chem. 278:43787-96
159. + exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human κ opioid receptor by enhancing its recycling rate. J. Biol. Chem. 277:27545-52
160. + exchanger regulatory factor family of PDZ proteins. Proc. Natl. Acad. Sci. USA 95:8496-501
161. Vargas GA, von Zastrow M. 2004. Identification of a novel endocytic recycling signal in the D1 dopamine receptor. J. Biol. Chem. 279:37461-69
162. Galet C, Hirakawa T, Ascoli M. 2004. The postendocytic trafficking of the human lutropin receptor is mediated by a transferable motif consisting of the C-terminal cysteine and an upstream leucine. Mol. Endocrinol. 18:434-46
163. Tanowitz M, von Zastrow M. 2003. A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J. Biol. Chem. 278:45978-86
164. Seachrist JL, Ferguson SS. 2003. Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci. 74:225-35
165. Hamelin E, Theriault C, Laroche G, Parent JL. 2005. The intracellular trafficking of the G protein-coupled receptor TPβ depends on a direct interaction with Rab11. J. Biol. Chem. 280:36195-205
166. Roosterman D, Cottrell GS, Schmidlin F, Steinhoff M, Bunnett NW. 2004. Recycling and resensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases. J. Biol. Chem. 279:30670-79
167. Fan GH, Lapierre LA, Goldenring JR, Sai J, Richmond A. 2004. Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis. Mol. Biol. Cell. 15:2456-69
168. 4 muscarinic acetylcholine receptor. J. Neurosci. 22:9776-84
169. 2B adenosine receptor trafficking. Biochemistry 39:12828-36
170. Vines CM, Revankar CM, Maestas DC, LaRusch LL, Cimino DF, et al. 2003. N-Formyl peptide receptors internalize but do not recycle in the absence of arrestins. J. Biol. Chem. 278:41581-84
171. Key TA, Vines CM, Wagener BM, Gurevich VV, Sklar LA, Prossnitz ER. 2005. Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins. Traffic 6:87-99
172. Boulay F, Rabiet MJ. 2005. The chemoattractant receptors FPR and C5aR: same functions - different fates. Traffic 6:83-86
173. Simaan M, Bedard-Goulet S, Fessart D, Gratton JP, Laporte SA. 2005. Dissociation of β-arrestin from internalized bradykinin B2 receptor is necessary for receptor recycling and resensitization. Cell Signal. 17:1074-83
174. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Hollt V, Schulz S. 2004. Differential β-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J. Biol. Chem. 279:21374-82
175. Kurten RC, Cadena DL, Gill GN. 1996. Enhanced degradation of EGF receptors by a sorting nexin, SNX1. Science 272:1008-10
176. Wang Y, Zhou Y, Szabo K, Haft CR, Trejo J. 2002. Down-regulation of protease-activated receptor-1 is regulated by sorting nexin 1. Mol. Biol. Cell 13:1965-76
177. Gullapalli A, Wolfe BL, Griffin CT, Magnuson T, Trejo J. 2006. An essential role of SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer-, hrs-, and tsg101-independent functions of sorting nexins. Mol. Biol. Cell 17:1228-38
178. Shi H, Rojas R, Bonifacino JS, Hurley JH. 2006. The retromer subunit vps26 has an arrestin fold and binds vps35 through its C-terminal domain. Nat. Struct. Mol. Biol. 13:540-46
179. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, et al. 2002. Modulation of postendocytic sorting of G protein-coupled receptors. Science 297:615-20
180. Simonin F, Karcher P, Boeuf JJM, Matifas A, Kieffer BL. 2004. Identification of a novel family of G protein-coupled receptor associated sorting proteins. J. Neurochem. 89:766-75
181. Bartlett SE, Enquist J, Hopf FW, Lee JH, Gladher F, et al. 2005. Dopamine responsiveness is regulated by targeted sorting of D2 receptors. Proc. Natl. Acad. Sci. USA 102:11521-26
182. Wojcikiewicz RJH. 2004. Regulated ubiquitination of proteins in GPCR-initiated signaling pathways. Trends Pharmacol. Sci. 25:35-41
183. 2-adrenergic receptor and β-arrestin. Science 294:1307-13
184. Marchese A, Benovic JL. 2001. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J. Biol. Chem. 276:45509-12
185. Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, Bunnett NW. 2005. c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J. Biol. Chem. 280:16076-87
186. Cottrell GS, Padilla B, Pikios S, Roosterman D, Steinhoff M, et al. 2006. Ubiquitin-dependent down-regulation of the neurokinin-1 receptor. J. Biol. Chem. 281:27773-83
187. Marchese A, Raiborg C, Santini F, Keen JH, Stenmark H, Benovic JL. 2003. The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev. Cell 5:709-22
188. Hislop JN, Marley A, von Zastrow M. 2004. Role of mammalian vacuolar protein-sorting proteins in endocytic trafficking of a nonubiquitinated G protein-coupled receptor to lysosomes. J. Biol. Chem. 279:22522-31
189. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, et al. 2003. Dishevelled 2 recruits β-arrestin 2 to mediate Wnt5A-stimulated endocytosis of frizzled 4. Science 301:1391-94
190. Mukherjee A, Veraksa A, Bauer A, Rosse C, Camonis J, Artavanis-Tsakonas S. 2005. Regulation of Notch signaling by nonvisual β-arrestin. Nat. Cell Biol. 7:1191-201
191. Chen W, Ren XR, Nelson CD, Barak LS, Chen JK, et al. 2004 Activity-dependent internalization of smoothened mediated by β-arrestin 2 and GRK2. Science 306:2257-60
192. Wilbanks AM, Fralish GB, Kirby ML, Barak LS, Li YX, Caron MG. 2004 β-Arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science 306:2264-67
193. Girnita L, Girnita A, Larsson O. 2003. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc. Natl. Acad. Sci. USA 100:8247-52
194. Grinita L, Shenoy SK, Sehat B, Vasilcanu R, Girnita A, et al. 2005. β-Arrestin is crucial for ubiquitination and downregulation of the insulin-like growth factor-1 receptor by acting as adapter for the MDM2 E3 ligase. J. Biol. Chem. 280:24412-19
195. Usui I, Imamura T, Huang J, Satoh H, Shenoy SK, et al. 2004. β-Arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. Mol. Cell. Biol. 24:8929-37
196. Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM. 2001. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 276:15688-95
197. Lin FT, Daaka Y, Lefkowitz RJ. 1998. β-Arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor. J. Biol. Chem. 273:31640-43
198. i-coupled receptors. J. Biol. Chem. 280:1016-23
199. Wang Y, Tang Y, Teng L, Wu Y, Zhao X, Pei G. 2006. Association of β-arrestin and TRAF6 negatively regulates Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 7:139-47
200. Chen W, Kirkbride KC, How T, Nelson CD, Mo J, et al. 2003. β-Arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling. Science 301:1394-97
201. Wu JH, Peppel K, Nelson CD, Lin FT, Kohout TA, et al. 2003. The adapter protein β-arrestin2 enhances endocytosis of the low density lipoprotein receptor. J. Biol. Chem. 278:44238-45
202. + exchanger NHE5 isoform. Proc. Natl. Acad. Sci. USA 102:2790-95
203. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, et al. 2005. Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling. Proc. Natl. Acad. Sci. USA 102:1442-47
204. Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ. 2005. Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl. Acad. Sci. USA 102:1448-53
205. Violin JD, Ren XY, Lefkowitz RJ. 2006. G protein-coupled receptor kinase specificity for β-arrestin recruitment to the β2-adrenergic receptor revealed by fluoresence resonance energy transfer. J. Biol. Chem. 281:20577-88
206. Potter RM, Maestas DC, Cimino DF, Prossnitz ER. 2006. Regulation of N-formyl peptide receptor signaling and trafficking by individual carboxyl-terminal serine and threonine residues. J. Immunol. 176:5418-25
207. Palmitessa A, Hess HA, Bany IA, Kim YM, Koelle MR, Benovic JL. 2005. Caenorhabditis elegans arrestin regulates neural G protein signaling and olfactory adaptation and recovery. J. Biol. Chem. 280:24649-62
208. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, et al. 2006. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc. Natl. Acad. Sci. USA 103:9691-96
209. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN. 2006. Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc. Natl. Acad. Sci. USA 103:1492-97
210. Premont RT, Gainetdinov RR. 2007. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu. Rev. Physiol. 69:in press
211. DeFea K. 2007. Stop that cell! β-Arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu. Rev. Physiol. 69:in press
212. Hupfeld CJ, Olefsky JM. 2007. Regulation of receptor tyrosine kinase by GRKs and β-arrestins. Annu. Rev. Physiol. 69:561-77